Eradication of pathogens from the nasopharynx after therapy of acute maxillary sinusitis with low- or high-dose amoxicillin/clavulanic acid

International Journal of Antimicrobial Agents

Volumn 26, Issue 5, 2005, Pages 416-419

  Brook, Itzhak ^a,b   Foote, Perry A ^a   Hausfeld, Jeffrey N ^a  

^a UNIVERSITY OF NORTH FLORIDA   (United States)

^b NONE   (United States)

Author keywords

Amoxicillin clavulanic acid; Haemophilus influenzae; Moraxella catarrhalis; Sinusitis; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AUGMENTIN XR;

ADULT; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG MEGADOSE; ERADICATION THERAPY; FEMALE; HAEMOPHILUS INFLUENZAE TYPE A; HUMAN; MAJOR CLINICAL STUDY; MALE; MAXILLA SINUSITIS; MORAXELLA CATARRHALIS; NASOPHARYNX; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; MALE; MAXILLARY SINUSITIS; MIDDLE AGED; MORAXELLA (BRANHAMELLA) CATARRHALIS; MORAXELLACEAE INFECTIONS; NASOPHARYNX; PNEUMOCOCCAL INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 26944496083     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2005.08.012     Document Type: Article

References (16)

1. C.J. Harrison, M.I. Marks, and D.F. Welch Microbiology of recently treated acute otitis media compared with previously untreated acute otitis media Pediatr Infect Dis 4 1985 641 646
2. S.A. Carlin, C.D. Marchant, P.A. Shurin, C.E. Johnson, D. Murdell-Panek, and S.J. Barenkamp Early recurrences of otitis media: reinfection or relapse? J Pediatr 110 1987 20 25
3. S.J. Barenkamp, P.A. Shurin, and C.D. Marchant Do children with recurrent Haemophilus influenzae otitis media become infected with a new organism or reacquire the original strain? J Pediatr 105 1984 533 537
4. W.A. Craig, and D. Andes Pharmacokinetics and pharmacodynamics of antibiotics in otitis media Pediatr Infect Dis J 15 1996 255 259
5. M.E. Pichichero, and C.L. Pichichero Persistent otitis media: I. Causative pathogens Pediatr Infect Dis J 14 1995 178 183
6. Sinus and Allergy Health Partnership. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg 2004;130(Suppl 1):1-45.
7. Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH. Manual of clinical microbiology. 7th ed. Washington, D.C.: ASM Press, 1999.
8. National Committee for Clinical Laboratory Standards. Methods for dilutional antimicrobial susceptibility tests for bacteria that grow aerobically. 4th ed. Approved standard M7-A4. Wayne, PA: NCCLS; 1995.
9. National Committee for Clinical Laboratory Standards. MIC testing supplemental tables (M100-S10). Wayne, PA: NCCLS; 2000.
10. D.H. O'Callaghan, A. Morris, S.M. Kirby, and A.H. Shingler Novel method for detection of beta-lactamase by using a chromogenic cephalosporin substrate Antimicrob Agents Chemother 1 1972 283 288
11. F. Ghaffar, L.S. Muniz, and K. Katz Effects of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media Clin Infect Dis 31 2000 875 880
12. F. Ghaffar, L.S. Muniz, and K. Katz Effects of large dosages of amoxicillin/clavulanate or azithromycin on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, nonpneumococcal alpha-hemolytic streptococci, and Staphylococcus aureus in children with acute otitis media Clin Infect Dis 15 2002 1301 1309
13. I. Brook, and A.E. Gober Eradication of Streptococcus pneumoniae in the nasopharyngeal flora of children with acute otitis media after amoxicillin-clavulanate therapy Antimicrob Agents Chemother 48 2004 1419 1421
14. W.A. Craig Overview of newer antimicrobial formulations for overcoming pneumococcal resistance Am J Med 117 Suppl. 3A 2004 16S 22S
15. G. Woodnutt, and V. Berry Two pharmacodynamic models for assessing the efficacy of amoxicillin/clavulanate against experimental respiratory tract infections caused by strains of Streptococcus pneumoniae Antimicrob Agents Chemother 43 1999 29 34
16. K. Seikel, S. Shelton, and G.H. McCracken Jr. Middle ear fluid concentrations of amoxicillin after large dosages in children with acute otitis media Pediatr Infect Dis J 16 1997 710 711